Spegra tablet is a fixed-dose combination antiretroviral medication manufactured by Emcure Pharmaceuticals Ltd, designed to treat HIV-1 infection in adults and adolescents (weighing at least 35-40kg). It combines three active ingredients—Dolutegravir (50mg), Emtricitabine (200mg), and Tenofovir Alafenamide (25mg)—into a single, once-daily tablet, enhancing adherence and reducing pill burden.